B&M: So David, let’s start by you just telling me a little bit about your VC firm, what is your history and your key focus? DG: Index was founded in 1996. In the…
This is the fourth of 4 weekly Polls hosted throughout July that will accompany the August edition of Drugs&Dealers Magazine ‘Lost in Translation: Tech Transfer and Start-up Capital’. This poll reviews the cash…
Removing the hype from IPO Dr Darrin Disley is President and CEO of Horizon Discovery. A life scientist with a track record of raising c$190 million in business financing from…
Biotech and Money, the industry’s newest and most innovative virtual, online and physical private biopharma community officially launched on 12th June with the ‘Biotechs and the City’ Evening Reception at Bird…
Biotech and Money, the industry’s newest and most innovative virtual, online and physical private biopharma community officially launched on 12th June with the ‘Biotechs and the City’ Evening Reception at Bird…
Biotech and Money, the industry’s newest and most innovative virtual, online and physical private biopharma community officially launched on 12th June with the ‘Biotechs and the City’ Evening Reception at Bird…
Facing up to the biotech IPO and financing challenge - PART TWO Biotech and Money, the industry’s newest and most innovative virtual, online and physical private biopharma community officially launched…
Biotech and Money, the industry’s newest and most innovative virtual, online and physical private biopharma community officially launched on 12th June with the ‘Biotechs and the City’ Evening Reception at…
It is proving harder and harder for early stage biotech’s in the UK to get funding from VCs. Many are hoping high net worth individuals can fill the void. I…
Whether your searching for VC capital, appealing to generalist investors or looking for new pharma partners, you need to be able to tell your story effectively. I’ve been asking a…
